Bentiromide |
|
II |
SEP / 98 |
Benzalkonium and its salts |
liquid preparations in concentrations of more than 2% |
II |
SEP / 98 |
BenzethidineN |
|
I |
JUN / 02 |
Benzethonium chloride |
liquid preparations in concentrations of more than 1% |
II |
SEP / 98 |
Benzocaine and its salts |
for parenteral or ophthalmic use |
II |
SEP / 98 |
Benzocaine and its salts. |
for topical use on mucous membranes for teething |
III |
SEP / 98 |
Benzocaine and its salts.. |
for topical application on the skin |
U |
|
Benzonatate |
|
III |
SEP / 98 |
Benzoyl peroxidePDL |
in concentrations greater than 5% or when sold in combination with another medicinal ingredient
|
I |
DEC / 13 |
Benzoyl peroxide. |
preparations of 5% or less as a single ingredient |
U |
MAY / 08 |
BenzphetamineC1 |
|
I |
JUN / 02 |
Benztropine or its saltsPDL |
including but not limited to benzatropine
|
I |
DEC / 13 |
Benzydamine or its saltsPDL |
|
I |
DEC / 13 |
Benzyl benzoate |
|
II |
SEP / 98 |
BenzylmorphineN |
|
I |
JUN / 02 |
Bepotastine or its salts or derivativesPDL |
|
I |
NOV / 16 |
BeractantPDL |
|
I |
DEC / 13 |
Berberis vulgaris |
Barberry |
III |
SEP / 98 |
Besifloxacin or its saltsPDL |
|
I |
DEC / 13 |
BetacetylmethadolN |
|
I |
JUN / 02 |
Betahistine or its saltsPDL |
|
I |
DEC / 13 |
Betaine or its saltsPDL |
for human use, when sold or recommended for the treatment of homocystinuria
|
I |
DEC / 13 |
Betaine or its salts. |
for veterinary use
|
I |
DEC / 13 |
BetameprodineN |
|
I |
JUN / 02 |
BetamethadolN |
|
I |
JUN / 02 |
BetaprodineN |
|
I |
JUN / 02 |
Betaxolol or its saltsPDL |
|
I |
DEC / 13 |
Bethanechol chloridePDL |
|
I |
DEC / 13 |
Bethanidine or its saltsPDL |
|
I |
DEC / 13 |
BevacizumabPDL |
|
I |
DEC / 13 |
Bezafibrate or its salts or derivativesPDL |
|
I |
DEC / 13 |
BicalutamidePDL |
|
I |
DEC / 13 |
Bictegravir or its saltsPDL |
|
I |
AUG / 18 |
Bilastine or its salts or derivativesPDL |
|
I |
AUG / 16 |
Bile salts |
|
U |
|
Bioflavanoids |
|
U |
|
Biperiden or its saltsPDL |
|
I |
DEC / 13 |
Bisacodyl |
when sold in concentrations of 5mg or less per oral dosage unit or 10mg or less per rectal dosage unit/suppository, in package sizes containing no more than 50mg of bisacodyl |
U |
JAN / 14 |
Bisacodyl and its salts |
(except when sold in concentrations of 5mg or less per oral dosage unit or 10mg or less per rectal dosage unit/suppository in package sizes containing no more than 50mg of bisacodyl)
|
III |
JAN / 14 |
Bishydroxycoumarin or its salts or derivativesPDL |
|
I |
DEC / 13 |
Bisoprolol or its saltsPDL |
|
I |
DEC / 13 |
Bitolterol or its saltsPDL |
|
I |
DEC / 13 |
BivalirudinPDL |
|
I |
DEC / 13 |
BleomycinPDL |
|
I |
DEC / 13 |
BlinatumomabPDL |
|
I |
AUG / 16 |
Boceprevir or its derivativesPDL |
|
I |
DEC / 13 |
BolandiolC3 |
|
I |
JUN / 02 |
BolasteroneC3 |
|
I |
JUN / 02 |
BolazineC3 |
|
I |
JUN / 02 |
BoldenoneC3 |
|
I |
JUN / 02 |
BolenolC3 |
|
I |
JUN / 02 |
Boric acid and its salts |
in preparations for systemic use, or ophthalmic preparations in concentrations over 2%[Note: does not apply to contact lens solutions intended to be rinsed off prior to insertion in the eye] |
II |
DEC / 98 |
Boric acid and its salts. |
in ophthalmic preparations in concentrations up to and including 2%, and in contact lens solutions intended to be rinsed off prior to insertion into the eye |
U |
DEC / 98 |
BortezomibPDL |
|
I |
DEC / 13 |
Bosentan or its salts or derivativesPDL |
|
I |
DEC / 13 |
Bosutinib or its saltsPDL |
including but not limited to Bosutinib methanoate
|
I |
AUG / 14 |
Botulinum toxinPDL |
including but not limited to onabotulinumtoxin A, incobotulinumtoxin A, abobotulinumtoxin A, rimabotulinumtoxin B, prabotulinumtoxin A
|
I |
DEC / 13 |
Brentuximab vedotinPDL |
|
I |
DEC / 13 |
Bretylium tosylatePDL |
|
I |
DEC / 13 |
Brexpiprazole or its saltsPDL |
|
I |
APR / 17 |
Brigatinib or its saltsPDL |
|
I |
AUG / 18 |
Brimonidine or its saltsPDL |
|
I |
DEC / 13 |
Brivaracetam or its derivativesPDL |
|
I |
AUG / 16 |
BrodalumabPDL |
|
I |
MAY / 18 |
BromalPDL |
|
I |
DEC / 13 |
Bromal hydratePDL |
|
I |
DEC / 13 |
Bromazepam and its saltsTS |
|
I |
SEP / 98 |
BrometonePDL |
|
I |
DEC / 13 |
Bromfenac or its saltsPDL |
|
I |
MAY / 15 |
BromisovalPDL |
|
I |
DEC / 13 |
Bromocriptine or its saltsPDL |
|
I |
DEC / 13 |
BromoformPDL |
|
I |
DEC / 13 |
Brompheniramine and its salts |
as a single entity for the treatment of allergies |
III |
JAN / 03 |
Brompheniramine and its salts. |
in combination products for the relief of cough and cold symptoms |
U |
JAN / 03 |
BrotizolamTS |
|
I |
JUN / 02 |
Buclizine |
|
II |
SEP / 98 |
Bufexamac |
|
II |
SEP / 98 |
Bumetanide or its salts or derivativesPDL |
|
I |
DEC / 13 |
Bupivacaine and its salts |
for topical use on mucous membranes except lozenges |
III |
SEP / 98 |
Bupivacaine and its salts |
for parenteral or ophthalmic use |
II |
SEP / 98 |
BuprenorphineN |
|
I |
JUN / 02 |
Bupropion or its saltsPDL |
|
I |
DEC / 13 |
Buserelin or its saltsPDL |
|
I |
DEC / 13 |
Buspirone or its saltsPDL |
|
I |
DEC / 13 |
BusulfanPDL |
|
I |
DEC / 13 |
ButabarbitalC2 |
|
I |
JUN / 02 |
Butacaine and its salts |
for ophthalmic or parenteral use |
II |
SEP / 98 |
ButalbitalC2 |
|
I |
JUN / 02 |
ButallylonalC2 |
|
I |
JUN / 02 |
Butaperazine or its saltsPDL |
|
I |
DEC / 13 |
Butenafine |
1% cream |
U |
SEP / 99 |
ButethalC2 |
|
I |
JUN / 02 |
Butoconazole or its saltsPDL |
|
I |
DEC / 13 |
Butorphanol and any salt thereofC2 |
|
I |
JUN / 02 |
Butyl chloral hydratePDL |
|
I |
DEC / 13 |
Cabergoline or its saltsPDL |
|
I |
DEC / 13 |
Cabozantinib or its saltsPDL |
|
I |
NOV / 18 |
CalcifediolPDL |
|
I |
JUL / 18 |
CalcipotriolPDL |
|
I |
DEC / 13 |
CalcitoninPDL |
|
I |
DEC / 13 |